Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics

British Journal of Haematology

Volumn 107, Issue 3, 1999, Pages 587-599

  Branford, S ^a   Hughes, T P ^b   Rudzki, Z ^b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b NONE

Author keywords

BCR ABL; Chronic myeloid leukaemia; Competitive PCR; Polymorphism; Real time quantitative PCR

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN;

ARTICLE; CANCER REGRESSION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032748325     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01749.x     Document Type: Article

References (35)

1. Allan, N.C., Richards, S.M. & Shepherd, P.C.A. (1995) UK Medical Research Council radomised, multicentre trial of interferon-α n1 for chronic myeloid leukaemia, improved survival irrespective of cytogenetic response. Lancet, 345, 1392-1397.
2. Collins, S., Coleman, H. & Groudine, M. (1987) Expression of bcr and bcr-abl fusion transcripts in normal and leukaemic cells. Molecular and Cellular Biology, 7, 2870-2876.
3. Cross, N.C.P., Hughes, T.P., Lin, E. O'Shea, P., Bungey, J., Marks, D.I., Ferrant, A., Martiat, P. & Goldman, J.M. (1993a) Minimal residual disease after allogeneic bone marrow transplantation for chronic mycloid leukaemia in first chronic phase, correlations with acute graft-versus-host disease and relapse. British Journal of Haematology, 84, 67-74.
4. Cross, N.C.P., Lin, F., Chase, A., Bungey, J., Hughes, T.P. & Goldman, J.M. (1993b) Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood, 82, 1929-1936.
5. Daley, G.Q., van Etten, R.A. & Baltimore, D. (1990) Induction of chronic myeloid leukemia by the P210 bcr/abl gene of the Philadelphia chromosome. Science, 247, 824-830.
6. Debate round-table (1997) Appropriate controls for RT-PCR. Leukaemia, 11, 871-881.
7. Gaiger, A., Henn, T., Horth, E., Geissler, K., Mitterbauer, G., Maier-Dobersberger, T., Greinix, H., Mannhalter, C., Haas, O.A., Lechner, K. & Lion, T. (1995) Increase of bcr-abl chimeric mRNA expression in tumour cells of patients with chronic myeloid leukemia precedes disease progression. Blood, 85, 2371-2378.
8. Hochhaus, A., Lin, F., Reiter, A., Skladny, H., Hehlmann, R., Goldman, J.M. & Cross, N.C.P. (1996) Quantitative molecular methods to monitor the response of CML patients to interferon-alpha. Bone Marrow Transplantation, 17, (Suppl. 3), S41-S44.
9. Hochhaus, A., Lin, F., Reiter, A., Skladny, H., van Rhee, F., Shepherd, P.C.A., Allan, N.C., Hehlman, R., Goldman, J.M. & Cross, N.C.P. (1995) Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-α. British Journal of Haematology, 91, 126-131.
10. Holland, P.M., Abrahamson, R.D., Watson, R., Will, S., Saiki, R.K. & Gelfand, D.H. (1991) Detection of specific polymerase chain reaction products by utilizing the 5′ to 3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proceedings of the National Academy of Sciences of the United States of America, 88, 7276-7280.
11. Hughes, T.P., Morgan, G.J., Martiat, P. & Goldman, J.M. (1991) Detection of residual leukemia after bone marrow transplantation for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood, 77, 874-878.
12. ISCN: an international system for human cytogenetic nomenclature (1995) In: Cytogenetics and Cell Genetics (ed. by F. Mitelman). Karger, Basel.
13. Kantarjian, H., Smith, T.L., O'Brian, S., Beren, M., Pierce, S. & Talpaz, M. (1995) Prolonged survival in chronic myelogenous leukaemia after cytogenetic response to interferon-α therapy. Annals of Internal Medicine, 122, 254-261.
14. + chronic myeloid leukaemia (CML) progenitor cells. Experimental Haematology, 21, 1073.
15. Kloke, O., Neiderle, N., Qiu, J.Y., Wandl, U., Moritz, T.M., Nagel-Hiemke, M., Hawig, I., Opalka, B., Seeber, S. & Becher, R. (1993) Impact of interferon-alpha induced cytogenetic improvement on survival in chronic myelogenous leukaemia. British Journal of Haematology, 83, 399-403.
16. Kruse, N., Pette, M., Toyka, K. & Rieckmann, P. (1997) Quantification of cytokine mRNA expression by RT-PCR in samples of previously frozen blood. Journal of Immunological Methods, 210, 195-203.
17. Lee, M.S., Kantarjian, H., Talpaz, M., Freidreich, E.J., Deisseroth, A., Trujillo, J.M. & Stass, S.A. (1992) Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy. Blood, 79, 1920-1923.
18. Lin, F., Goldman, J.M., Cross, N.C.P. (1994) A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia. British Journal of Haematology, 86, 683-685.
19. Lin, F., van Rhee, F., Goldman, J.M. & Cross, N.C.P (1996) Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood, 87, 4471-4478.
20. Lion, T., on behalf of the European Investigators on Chronic Myeloid Leukaemia (1994) Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. Bone Marrow Transplantation, 14, 505-509.
21. Lion, T., Gaiger, A., Henn, T., Horth, E., Haas, O.A., Geissler, K. & Gadner, H. (1995) Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon. Leukemia, 9, 1353-1360.
22. Lion, T., Henn, T., Gaiger, A., Kalhs, P. & Gadner, H. (1993) Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia. Lancet, 341, 275-276.
23. Lion, T., Izraeli, S., Henn, T., Gaiger, A., Mor, W. & Gadner, H. (1992) Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction. Leukemia, 6, 495-499.
24. Malinge, M.C., Mahon, F.X., Delfau, M.H., Daheron, L., Kitzis, A., Gulihot, F., Tanzer, J. & Grandchamp, B. (1992) Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy. British Journal of Haematology, 82, 701-707.
25. Mensink, E., van de Locht, A., Schattenberg, A., Linders, E., Schapp, N., Guerts van Kessel, A. & De Whitte, T. (1998) Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. British Journal of Haematology, 102, 768-774.
26. Miyamura, K., Takeo, T., Kataoka, T., Tahara, T., Tanimoto, M. & Saito, H. (1993) Detection of minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukaemia: rationale for bone marrow transplantation from the polymerase chain reaction point of view. Leukaemia and Lymphoma, 11, 181-189.
27. Morgan, G.J., Hughes, T.P., Janssen, J.W.D., Gow, J., Guo, A.P., Goldman, J.M., Wiedemann, L.M. & Bartram, C.R. (1989) Polymerase chain reaction for detection of residual leukaemia. Lancet, i, 928-929.
28. Roth, M.S., Antin, F.H., Ash, R., Terry, V.H., Gotlieb, M., Silver, S.M. & Ginsburg, D. (1992) Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood, 79, 276-282.
29. Suryanarayana, K., Wiltrout, T.A., Vasquez, G.M., Hirsch, V.M. & Lifson, J.D. (1998) Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Research and Human Retroviruses, 14, 2, 183-189.
30. Talpaz, M., Estrov, Z., Kantarjian, H., Ku, S., Foteh, A. & Kurzrock, R. (1994) Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Journal of Clinical Investigation, 94, 1383-1389.
31. The Italian Cooperative Study Group on Chronic Myeloid Leukaemia (1994) Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. New England Journal of Medicine, 330, 820-825.
32. Tchirkov, A., Giollant, M., Tavernier, F., Briancon, G., Tournilhac, O., Kwiatkowski, F., Philippe, P., Choufi, B., Demeocq, F., Travade, P. & Malet, P. (1998) Interphase cytogenetics and competitive RT-PCR for residual disease monitoring in patients with chronic myeliod leukaemia during interferon-α therapy. British Journal of Haematology, 101, 552-557.
33. van Rhee, F., Lin, F., Cullis, J.O., Spencer, A., Cross, N.C.P., Chase, A., Garicochea, B., Bungey, J., Barrett, J. & Goldman, J.M. (1994) Relapse of chronic myeloid leukemia after allogeneic transplant: the case for giving donor leukocyte transfusions before the onset of hematological relapse. Blood, 83, 3377-3383.
34. Webber, L.M. & Garson, O.M. (1983) Fluorodeoxyuridine synchronization of bone marrow cultures. Cancer Genetics and Cytogenetics, 8, 123-132.
35. Wetzler, M., Talpaz, M., Van Ellen, R., Hirsh-Ginsberg, C., Beren, M. & Kurzrock, R. (1993) Subcellular localisation of Bcr, Abl and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid maturation. Journal of Clinical Investigation, 92, 1925-1939.